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Summary
During spermatogenesis, germ cells initially expand expo-
nentially through mitoses. A majority of these cells are
then eliminated through p53-mediated apoptosis tomaintain
germline homeostasis [1–4]. However, the activity of p53
must be precisely modulated, especially suppressed in
postmitotic spermatogenic cells, to guarantee robustness
of spermatogenesis. Currently, how the suppression is
achieved is not understood. Here, we show that Pumilio 1,
a posttranscriptional regulator, binds to mRNAs represent-
ing 1,527 genes, with significant enrichment for mRNAs
involved in pathways regulating p53, cell cycle, and MAPK
signaling. In particular, eight mRNAs encoding activators
of p53 are repressed by Pumilio 1. Deleting Pumilio 1 results
in strong activation of p53 and apoptosis mostly in sper-
matocytes, which disrupts sperm production and fertility.
Removing p53 reduces apoptosis and rescues testicular hy-
potrophy in Pumilio 1 null mice. These results indicate that
key components of the p53 pathway are coordinately regu-
lated by Pumilio 1 at the posttranscriptional level, which
may exemplify an RNA operon.
Results and Discussion
Spermatogenesis in mammals is a complex process in which
germline stem cells undergo 9–11 rounds of mitosis, followed
by meiosis and a cellular morphogenic process called sper-
miogenesis that transforms round haploid spermatids into
sperm. The multiple rounds of mitoses generate excess sper-
matogonia that must be eliminated to maintain the homeo-
stasis of spermatogenesis. This is accomplished in part by
p53-mediated apoptosis [1–4]. The temporally and spatially
specific activation of p53 must be precisely controlled so
that not only excess spermatogonia are eliminated, but
enough germ cells must also survive the elimination to
generate a sufficiently large number of sperm. However, how
this control is achieved in mammals remains unknown. Here,
we show that Pumilio 1 (Pum1), through coordinated posttran-
scriptional regulation of multiple factors in the p53 pathway,
represses p53 activation and apoptosis after spermatogonial
division.
Pum1 is one of the two members (Pum1 and Pum2) of the
PUF (Pumilio/FBF) protein family in the mouse. Its homolog
in Drosophila, Pum, is a posttranscriptional regulator essential
for a variety of germline processes, such as primordial germ
cell proliferation [5], germline stem cell self-renewal [6, 7],*Correspondence: haifan.lin@yale.eduovarian morphogenesis, and oviposition [5]. Pum binds to
a defined motif with a UGUAHAUA core in the 30 untranslated
region (30 UTR) of its target mRNAs and mediates translational
repression and/or mRNA decay [8, 9]. PUF proteins in Caeno-
rhabditis elegans are also known to be involved in multiple
steps of germline development [10, 11]. In contrast to the crit-
ical roles of Pum proteins in the Drosophila and C. elegans
germline, mouse Pum2 is not essential for spermatogenesis
[12], calling for an understanding of Pum1 in the mouse.
Pum1 Is Expressed in the Cytoplasm
of Spermatogenic Cells
Wefirst examined the expression ofPum1 in 11mouse organs.
ThemRNA and protein levels weremeasured by qRT-PCR and
immunoblot analysis, respectively. Both analyses showed that
Pum1 is highly expressed in the testis (Figures 1A and S1A
available online). During the development of the testis, Pum1
is expressed 2 days postpartum (dpp) and then starts to in-
crease at 14 dpp when pachytene spermatocytes first appear
(Figure S1B). Immunofluorescence microscopy using an anti-
Pum1 antibody further revealed that Pum1 is expressed in
the cytoplasm of spermatocytes along with other germ cell
types (Figures 1B and S1C). To confirm the subcellular locali-
zation of Pum1, we separated adult testicular lysates into cyto-
plasmic and nuclear fractions. Pum1 was detected almost
exclusively in the cytoplasm as indicated by immunoblot anal-
ysis (Figure 1C). This is consistent with the reported role of
Drosophila and C. elegans PUF proteins in regulating the
stability and translation of its target mRNAs [13–17].
Pum1 Null Males Show Significantly Reduced Sperm
Counts and Fertility
To understand the role of Pum1 in development, we generated
Pum1-null mice for phenotypic analysis (Figure S1D). The loss
of Pum1 protein was confirmed by immunoblot analysis of
testes from five Pum12/2 mice (Figure S1E). Pum12/2 mice
are viable and grow to adulthood without apparent defects
except that they are 18% (body weight, 62.1% SEM; p =
0.0003) smaller than wild-type mice at 8 weeks of age
(Figure S1F).
However, testicular hypoplasia was observed in all Pum12/2
males examined. The average testicular weight of Pum12/2
mice is 34% (61.5% SEM; p = 2.28 3 10216) lower than
that of wild-type mice at 8 weeks of age (Figure S1G). In addi-
tion, the mature sperm count of Pum12/2 males is reduced
by 80% (62.0% SEM; p = 1.40 3 10216) at 8 weeks of age
and remains at this low level throughout adult life (Figure 1D).
Consistently, the fertility of Pum12/2 males is reduced by
41% (63.2% SEM; p = 1.56 3 10213) when compared to
the wild-type level (Figure 1E). Taken together, these data
indicate that spermatogenesis is compromised in Pum12/2
males.
Spermatocytes in Pum1 Null Testes Display
Increased Apoptosis
To understand which step of spermatogenesis is impaired in
the Pum12/2 mice, we examined the testicular histology by
hematoxylin and eosin staining (Figures 1F and 1G) and
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Figure 1. Pum1 Expression and Function in the Testis
(A) qRT-PCR analysis of Pum1 mRNA levels in different
organs and tissues, as normalized to Gapdh. ESCs,
embryonic stem cells; BMW, bone marrow. Error bars
represent SD.
(B) Immunofluorescence microscopy of Pum1 in wild-
type testes thin sections. Sg, spermatogonium; Sc,
spermatocyte; Sd, spermatid.
(C) Immunoblot analysis of Pum1 in testicular cyto-
plasmic and nuclear fractions. Nu, nucleus; Cy, cyto-
plasm.
(D) Mature sperm counts in wild-type and Pum1 mutant
males at different ages, with error bars indicating SEM.
(E) Size of litters sired by wild-type and Pum1 mutant
males, with error bars indicating SEM.
(F and G) Testicular histology revealed by hematoxylin
and eosin (H&E) staining in wild-type (F) and Pum1 null
(G) mice. Arrow points to a spermatogenic cell under-
going cell death.
(H) Quantification of apoptotic cells in adult wild-type and
Pum1 mutant testes. Apoptosis was determined by
TUNEL analysis. For each mouse analyzed, apoptotic
cells were counted in 80 random seminiferous tubule
sections and are presented as number per ten random
tubule cross-sections, with error bars showing SD.
***p < 0.001.
Scale bars in (B) and (F) represent 50 mm.
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421periodic acid-Schiff staining (Figures S2A and S2B). The global
morphology of Pum12/2 testes looks normal, containing the
complete lineage of germ cells. Acrosome morphogenesis is
normal in Pum12/2 testes (Figures S2A and S2B), implicating
normal spermiogenesis up to the round spermatid stage.
Mature sperm are present (Figure 1D), indicating that sper-
matogenesis can reach completion for some of the Pum12/2
spermatogenic cells. In addition, Ki-67 immunohistochemistry
analysis showed that the division rates of spermatogonia and
spermatocytes are not affected in Pum12/2 testes (Figures
S2C–S2E). This is confirmed by the normal level of phospho-
histone 3, another marker of cell division, in Pum12/2 testes,
as revealed by immunoblot analysis (Figures S2F and
S2G). Furthermore, serum testosterone level is unchanged in
Pum12/2 mice, indicating normal steroidogenesis (Fig-
ure S2H). However, Pum12/2 spermatocytes more frequently
contain enlarged nuclei and condensed chromatin, suggestive
of apoptosis (Figures 1F and 1G). To investigate this defect
further, we conducted a terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) assay in 16 adult Pum1+/+,
Pum1+/2, and Pum12/2 males. This analysis revealed that
apoptosis in Pum1+/2 and Pum12/2 testes is elevated by
2.7-fold (60.29 SD; p = 0.0002) and 6.8-fold (61.02 SD; p =
4.22 3 1025), respectively (Figures 1H and S2I–S2K). More-
over, Apoptosis is elevated mostly in primary spermatocytes
(Figures S2L–S2N) in which Pum1 is normally expressed at
high levels. Moreover, in the testes of Pum12/flox;Vasa-cre+
mice where Pum1 is knocked out only in the germline,
apoptosis is also elevated by 7.5-fold (60.24 SD; p = 1.98 3
1027) from wild-type level (Figures 1H, S2O, and S2P). Thissuggests that the apoptosis phenotype in
Pum1 mutant testes is germline autonomous.
Spermatocytes in Pum1 Null Testes Are
Prematurely Released into the Epididymis
We then tracked the behavior of the apoptotic
cells in the reproductive tract and found thatthe lumen of the epididymis in Pum12/2 mice contains unex-
pected round cells with aberrant morphology (Figures S3A–
S3C). These cells are positive for Miwi (Figures S3D and
S3E), a protein specifically expressed in spermatocytes
and early spermatids. These cells also showed positive stain-
ing for TUNEL (Figures S3F and S3G). This indicates that
these cells are apoptotic spermatocytes that are expelled
from the testis rather than cells derived from the epididymis
epithelium.
Pum1 Binds to mRNAs Representing 1,527 Genes
in the Testis
To understand the mechanism of elevated apoptosis in the
Pum12/2 testis, we wanted to know which mRNAs are tar-
geted by Pum1 in the testis. To this end, we performed
a genome-wide target identification of Pum1 using ribonucleo-
protein-immunoprecipitation followed by microarray (RIP-
Chip). The Pum1 ribonucleoprotein (RNP) complexes were
precipitated from total testicular lysates with an anti-Pum1
antibody coupled to protein A Sepharose beads. RNAs associ-
ated with Pum1 were extracted and analyzed by hybridization
to a mouse cDNA microarray (Illumina Mouse Chip M6). To
identify nonspecifically precipitated RNAs, we used Pum12/2
testicular lysates in parallel experiments as negative controls.
We identified 3,687 transcripts that are consistently associ-
ated with Pum1, representing 1,527 Ensembl genes (false
discovery rate < 5%; Figure 2A and Table S1). Similar studies
performed on human PUM1 protein in HeLa S3 cancer
cells identified a similar number of mRNA targets [18, 19]. Mul-
tiple expectation maximization for motif elicitation (MEME)
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Figure 2. Pum1 Binds to and Represses mRNA
Targets via a Defined Binding Motif
(A) mRNAs associated with Pum1. Three inde-
pendent experiments using wild-type testi-
cular lysates and two mock experiments using
Pum12/2 testicular lysates are shown. The
Pum1 target mRNAswere coimmunoprecipitated
by an anti-Pum1 antibody. mRNAs associated
with Pum1 were analyzed by mouse cDNAmicro-
arrays. ENS, Ensembl; FDR, false discovery rate.
(B) The consensus sequence among Pum1-asso-
ciated mRNAs. A de novo sequence motif search
was performed using the top 124 Pum1-asso-
cated mRNAs by multiple expectation maximiza-
tion for motif elicitation (MEME).
(C) Number of motifs per 1 kb of sequence in the
50 UTRs, protein coding sequence (CDS), and 30
UTRs of Pum1 target mRNAs.
(D and E) Expression levels of select Pum1-asso-
ciated mRNAs and their protein levels in wild-
type, Pum1+/2, and Pum12/2 testes. Blue lines
indicate non-Pum1 targets, red lines indicate
Pum1 targets that are p53 regulators, and orange
lines indicate Pum1 targets that are not p53 regu-
lators. Error bars in (D) indicate SEM.
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422analysis revealed an eight-nucleotide consensus sequence,
UGUAHAUA, that exists among the Pum1 target mRNAs (Fig-
ure 2B). This motif predominantly resides in their 30 UTRs (Fig-
ure 2C) and is the same as those found in mRNA targets of
yeast Puf3 [20], Drosophila Pum [9], and human PUM1 and
PUM2 [18, 19], indicating that the Pum binding motif is highly
conserved.
Pathway analysis using MetaCore (version 6.7 build 28822)
was performed on 656 pathways to which genes on the Illu-
mina mouse chip (M6) can be mapped. Pum1-associtated
mRNAs are enriched in 11 pathways (p < 0.001) that regulate
p53 activation, cell cycle, and mitogen-activated protein
kinase (MAPK) signaling (Table S2 and Figures S4A–S4C),
which is also consistent with the pathways targeted by human
PUM1 in HeLa S3 cancer cells [18, 19]. In the p53-regulating
pathways, nine mRNAs encoding factors that regulate p53-
mediated apoptosis are Pum1 targets. Among them,
Map3k1, Map2k3, and Daxx activate p38 MAPK, which in
turn activates p53 [21–25]; Map2k7 together with Map3k1 acti-
vates JNK, which in turn activates p53 [22, 26]; Sae1, Uba2,
Pias1, and Pias2 are sumoylation ligases that prime p53 forinducing apoptosis [27]; and Mdm2 is
a ubiquitin ligase for p53 that primes it
for degradation [28, 29].
Pum1 Represses Its Target mRNAs in
Pathways that Regulate p53 Activity
Because Drosophila Pum promotes the
decay of its targetmRNAs and/or blocks
their translation [13–15], we wanted to
understand how murine Pum1 regulates
its target mRNAs. To this end, we
compared the expression levels of the
nine regulators of p53 between wild-
type, Pum1+/2, and Pum12/2 testes,
along with another five Pum1 target
mRNAs and seven nontarget mRNAs as
controls. qRT-PCR analysis revealed
that all seven nontarget mRNAs remainat wild-type levels in Pum12/2 testes, whereas 10 out of 14
Pum1 target mRNAs are slightly elevated in Pum12/2 testes,
suggesting thatPum1playsaminor role in reducing thestability
of its targetmRNAs (Figure 2D).More significantly, immunoblot
analysis revealed the elevation of seven out of the nine Pum1
target genes that are p53 regulators at the protein level in
Pum12/2 testes, except for Daxx and Mdm2 (Figure 2E). In
addition, Cdk1 andCdk2, two other Pum1 targets, are elevated
at the protein level (Figure 2E). In contrast, the protein levels of
Cul3, Map2k2, Map2k4, and Map3k5, which are not Pum1
targets, remain at the same levels in Pum12/2 testes (Figure
2E). The scale of elevation at the protein level (2- to 10-fold) is
much larger than that at the mRNA level (mostly within 2-fold;
Figure S4D), suggesting that Pum1 regulates its target mRNAs
mostly via translational repression.
p53 Is Overactivated in Spermatocytes in Pum1Null Testes
Pum1 represses at least two factors, Map2k3 and Map3k1,
that activate p53 by activating the p38 MAPK (Figures 2E,
3A, and 3B). We hypothesized that removing Pum1 would
lead to elevated activation of p38. Indeed, immunoblot
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Figure 3. Pum1 Deficiency Leads to Activation of
p38 MAPK, JNK, and p53
(A) Proteins encoded by Pum1 target mRNAs
activate p53 through the MAPK signaling
pathway.
(B) Immunoblot analysis of total and activated
levels of p38, JNK, and Map3k1 in total testicular
lysates. Although the total protein levels of p38
and JNK remain unchanged, phosphorylated
p38 (Thr180/Tyr182) and JNK (Thr183/Tyr185)
are increased in Pum12/2 testes. Map3k1 is
a Pum1 target that is upstream of both p38 and
JNK. Both its total and phosphorylated
(Thr1383) forms are elevated in Pum12/2 testes.
(C–H) Immunofluorescence microscopy of acti-
vated p38 in testicular thin sections. DAPI stain-
ing (E and F) provides nucleus morphology that
enables identification of spermatogonium (Sg),
spermatocyte (Sc), and spermatid (Sd). The
strongest elevation of p38 activation in Pum12/2
testes occurs in primary spermatocytes (C, D,
G, and F; in G and F, p38 and DAPI are in red
and blue, respectively).
(I and J) Immunofluorescencemicroscopy of acti-
vated p53 (Ser15) in testicular thin sections.
White arrowheads indicate some of the sper-
matocytes with activated p53. Extratubular green
fluorescence is nonspecific background from
Leydig cells.
Scale bars in (C), (E), (G), and (I) represent 20 mm.
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423analysis showed an increase of phosphorylated p38 (Thr180/
Tyr182) representing activated p38 in Pum12/2 testes, where-
as its total protein level remains unchanged (Figure 3B). Simi-
larly, the phosphorylated JNK (Thr183/Tyr185), representing
activated JNK, is elevated when its upstream kinase, Map2k7,
is increased due to Pum1 deficiency (Figures 3A and 3B).
Immunofluorescence analysis showed that the strongest
activation of p38 under Pum1 deficiency indeed occurs in
primary spermatocytes (Figures 3C–3H). This is in agreement
with our observations that Pum1 is most abundant in primary
spermatocytes and that apoptosis is elevated in these cells
under Pum1 deficiency.
The activated p38 phosphorylates p53 at Ser15 to prime p53
for proapoptotic transcription [21, 23, 24]. Consistently, in
wild-type testes, p53 is activated only in a small number of
spermatogonia; however, in Pum12/2 testes, the activated
form of p53 is extensively present in a large number of sper-
matocytes (Figures 3I and 3J). To confirm the activation of
p53, the transcription of four p53 target genes was examined
via qRT-PCR in total testicular lysates. Among them, Bax, Cas-
pase 6, and Noxa showed increased mRNA level in Pum12/2
testes (Figure S4E). The overactivation of p53 can be partially
rescued by an inhibitor of p38 (SB239063, intravenously at
15 mg/ml blood), suggesting p53 is overactivated in part via
p38 in the Pum12/2 testis.To further confirm the regulation of
p53 by Pum1, we crossed the Pum12/2
mice with a Trp53 mutant line [30]. At
15 dpp, Pum12/2 testes contain signifi-
cantly smaller seminiferous tubules
than wild-type testes (Figures 4D and
4E), presumably due to an overkill of
germ cells. Removing p53 partially
restores this morphological defect (Fig-
ure 4F). TUNEL analysis of17 mice at15 dpp revealed that removing p53 effectively reduces
apoptosis in Pum1mutant testes in a dose-dependent manner
(Figure 4G). Moreover, removing p53 also rescues the testis
hypotrophy in Pum12/2 testes (Figure 4H). These data indicate
that p53 is a major mediator of the Pum1 function in maintain-
ing the homeostasis of the mouse testicular germline.
Conclusions
Previous studies have shown that p53-mediated apoptosis is
used by mammals to eliminate excessive spermatogonia in
order to maintain germline homeostasis [1–4]. Our data
suggest that when a normal number of spermatogonia differ-
entiate into spermatocytes, p53-mediated apoptosis must be
suppressed to avoid the overkill of spermatocytes, and that
this is achieved at least in part by Pum1 and its coordinated
posttranscriptional suppression of multiple activators of p53
(Figure 4I).
In addition, Pum1 binds to mRNAs from 1,527 genes. Most
of these mRNAs may be true targets of Pum1 because 9 out
of 11 Pum1 target mRNAs are elevated at the protein level
under Pum1 deficiency (Figure 2E). The biological effects of
Pum1-mediated regulation on these numerous targets await
further investigation; why Pum12/2 mice are 18% smaller
than wild-type mice (Figure S1D) may find an answer in the
many Pum1 target mRNAs.
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Figure 4. Inhibition of p38 Reduces p53 Activa-
tion, and Removing p53 Rescues Pum1 Phe-
notype
(A–C) Effects of p38 inhibition on p53 overactiva-
tion in Pum12/2 testes.
(D–F) H&E staining of thin-sectioned testes
from wild-type (D), Pum12/2 (E), and Pum12/2;
Trp532/2 testes (F) at 15 days postpartum (dpp).
(G) Removing p53 reduces apoptosis in Pum12/2
testes at 15 dpp. Apoptotic cells were counted
in 80 random seminiferous tubule sections and
are presented as number per ten random tubule
cross-sections, with error bars represent-
ing SEM.
(H) Removing p53 rescues the testis hypotrophy
in Pum12/2 mice at 15 dpp. Error bars represent
SEM.
(I) Model illustrating that Pum1 represses eight
mRNAs that encode activators of p53. Pum1
binds to these different mRNAs through
a conserved binding motif in their 30 UTRs.
Scale bars in (C) and (D) represent 5 and 50 mm for
(A–C) and (D–F), respectively.
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424Furthermore, our data provide in vivo evidence in support
of the RNA operon hypothesis proposed by Keene and
colleagues [31, 32]. Unlike DNA operons, cistrons in an
RNA operon (mRNAs) are not physically linked. Instead,
each mRNA cistron carries a common sequence motif that
is recognized by a shared regulator. On one hand, this
allows efficient regulation of a pathway because multiple
factors in it can be targeted by a single regulator, as demon-
strated by Pum1 and its repression of eight activators of
p53. On the other hand, each mRNA may carry multiple
motifs recognized by different regulators and thus partici-
pate in more than one RNA operons. Lastly, even a single
regulator can exert differential regulation toward different
mRNA targets within an operon [33, 34]. These com-
bined regulatory effects offer enormous capacity for pre-
cise regulation of many genes with biologically relevant
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